110 related articles for article (PubMed ID: 7646526)
21. A safe, effective in vivo gene therapy for melanoma using tyrosinase promoter-driven cytosine deaminase gene.
Cao G; Zhang X; He X; Chen Q; Qi Z
In Vivo; 1999; 13(2):181-7. PubMed ID: 10363176
[TBL] [Abstract][Full Text] [Related]
22. Augmentation of melanoma-specific gene expression using a tandem melanocyte-specific enhancer results in increased cytotoxicity of the purine nucleoside phosphorylase gene in melanoma.
Park BJ; Brown CK; Hu Y; Alexander HR; Horti J; Raje S; Figg WD; Bartlett DL
Hum Gene Ther; 1999 Apr; 10(6):889-98. PubMed ID: 10223723
[TBL] [Abstract][Full Text] [Related]
23. Effect of Angelica gigas extract on melanogenesis in B16 melanoma cells.
Lv N; Koo JH; Yoon HY; Yu J; Kim KA; Choi IW; Kwon KB; Kwon KS; Kim HU; Park JW; Park BH
Int J Mol Med; 2007 Nov; 20(5):763-7. PubMed ID: 17912471
[TBL] [Abstract][Full Text] [Related]
24. AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation.
Madireddi MT; Dent P; Fisher PB
J Cell Physiol; 2000 Oct; 185(1):36-46. PubMed ID: 10942517
[TBL] [Abstract][Full Text] [Related]
25. Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C.
Park HY; Russakovsky V; Ao Y; Fernandez E; Gilchrest BA
Exp Cell Res; 1996 Aug; 227(1):70-9. PubMed ID: 8806453
[TBL] [Abstract][Full Text] [Related]
26. The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells.
Lefort K; Rouault JP; Tondereau L; Magaud JP; Doré JF
Oncogene; 2001 Nov; 20(50):7375-85. PubMed ID: 11704867
[TBL] [Abstract][Full Text] [Related]
27. Expression of tyrosinase-related protein 2/DOPAchrome tautomerase in the retinoblastoma.
Udono T; Takahashi K; Yasumoto K; Yoshizawa M; Takeda K; Abe T; Tamai M; Shibahara S
Exp Eye Res; 2001 Mar; 72(3):225-34. PubMed ID: 11180971
[TBL] [Abstract][Full Text] [Related]
28. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
29. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
[TBL] [Abstract][Full Text] [Related]
30. Triggering of antitumor activity through melanoma-specific transduction of a constitutively active tumor necrosis factor (TNF) R1 chimeric receptor in the absence of TNF-alpha.
Bazzoni F; Regalia E
Cancer Res; 2001 Feb; 61(3):1050-7. PubMed ID: 11221832
[TBL] [Abstract][Full Text] [Related]
31. Regulation of mda-7 gene expression during human melanoma differentiation.
Madireddi MT; Dent P; Fisher PB
Oncogene; 2000 Mar; 19(10):1362-8. PubMed ID: 10713678
[TBL] [Abstract][Full Text] [Related]
32. An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.
Ulasov IV; Rivera AA; Nettelbeck DM; Rivera LB; Mathis JM; Sonabend AM; Tyler M; Wang M; Douglas JT; Lesniak MS
Int J Oncol; 2007 Nov; 31(5):1177-85. PubMed ID: 17912445
[TBL] [Abstract][Full Text] [Related]
33. Activation of the tyrosinase gene promoter by neurofibromin.
Suzuki H; Takahashi K; Yasumoto K; Shibahara S
Biochem Biophys Res Commun; 1994 Dec; 205(3):1984-91. PubMed ID: 7811291
[TBL] [Abstract][Full Text] [Related]
34. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
35. Suppression of tyrosinase gene expression by bromodeoxyuridine in Syrian hamster melanoma cells is not due to its incorporation into upstream or coding sequences of the tyrosinase gene.
Rauth S; Davidson RL
Somat Cell Mol Genet; 1993 May; 19(3):285-93. PubMed ID: 8332936
[TBL] [Abstract][Full Text] [Related]
36. Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: possible strategy for inducing cancer cell suicide.
Maxwell IH; Maxwell F; Glode LM
Cancer Res; 1986 Sep; 46(9):4660-4. PubMed ID: 3460697
[TBL] [Abstract][Full Text] [Related]
37. Establishment of a melanogenesis regulation assay system using a fluorescent protein reporter combined with the promoters for the melanogenesis-related genes in human melanoma cells.
Lin CC; Yang CH; Lin YJ; Chiu YW; Chen CY
Enzyme Microb Technol; 2015 Jan; 68():1-9. PubMed ID: 25435499
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of gene expression and melanin production of human tyrosinase gene loaded in elastic cationic niosomes.
Khositsuntiwong N; Manosroi A; Götz F; Werner RG; Manosroi W; Manosroi J
J Pharm Pharmacol; 2012 Oct; 64(10):1376-85. PubMed ID: 22943168
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of combined gene regulatory elements for transcriptional targeting of suicide gene expression to malignant melanoma.
Rothfels H; Paschen A; Schadendorf D
Exp Dermatol; 2003 Dec; 12(6):799-810. PubMed ID: 14714561
[TBL] [Abstract][Full Text] [Related]
40. Hormonal regulation of melanogenesis in mouse melanoma and in human melanocytes.
Fuller BB; Rungta D; Iozumi K; Hoganson GE; Corn TD; Cao VA; Ramadan ST; Owens KC
Ann N Y Acad Sci; 1993 May; 680():302-19. PubMed ID: 8512220
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
